Since nitric oxide, i.e., generated from iNOS, may have a pathogenic role in MS [105], it is possible that the transportation of nitric oxide by albumin could be beneficial or deleterious depending on whether it was being removed or delivered, respectively. The gene discussed is ALB; the disease is myeloid sarcoma.